1-866-61-EISAI (1-866-613-4724)

Monday – Friday, 8am to 8pm ET

Financial Assistance

Eisai Assistance Program

The Eisai Assistance Program can provide information to patients and healthcare professionals about coverage for ALOXI® and programs to help patients afford their medication.  Depending on your financial situation and clinical status, resources may be available to help with patient costs for ALOXI®.

The Eisai Assistance Program can also provide information about the ALOXI® Patient Assistance Program which provides support to customers who need assistance paying for ALOXI®. This program provides ALOXI® at no cost to financially needy patients who meet program eligibility criteria.

Have Your Physician’s Office Contact Us

Eisai Assistance Program

Phone: 1-866-61- EISAI (1-866-613-4724)
Fax:1-866-57-EISAI (1-866-573-4724)
Monday – Friday, 8am – 8pm ET

ALOXI® Patient Assistance Program

Eisai has created the ALOXI® Patient Assistance Program for customers who need assistance paying for ALOXI®. This program provides ALOXI® at no cost to financially needy patients who meet program eligibility criteria.

Healthcare providers can call the ALOXI® Patient Assistance Program at 1-866-61-EISAI (1-866-613-4724) to determine eligibility. The hours of operation are Monday through Friday, 8am to 8pm ET.

Eisai reserves the right, at its sole discretion, to discontinue the Patient Assistance Program or change the qualifications at any time. All patient information remains confidential. Product supply for the program depends upon availability.

Do You Need Educational Assistance?

Programs run by Patient Support Foundations offer financial and educational assistance.

Discover Tips to Cope with Chemotherapy

ALOXI® is an anti-nausea medication that may help you cope with nausea and vomiting associated with chemotherapy.

Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record

+ Expand - Collapse

Indication in Adults

ALOXI® injection is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Indication in Pediatrics

ALOXI® injection is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.

Important Safety Information

  • ALOXI® can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain
  • The most common side effects of ALOXI® in adults are headache and constipation
  • Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed
  • Adverse Reactions

  • In pediatric patients, while they require a higher dose of palonosetron, the safety profile is consistent with the established profile in adults; however, adverse reactions were reported in < 0.1%="" of="">
  • In adults, the most commonly reported adverse drug reactions include headache (9%) and constipation (5%)
  •  

    For more information about ALOXI®, talk to your doctor or see full prescribing information Prescribing Information.

    ALOXI® is available by prescription only.

    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit http://www.FDA.gov/medwatch or 1-800-FDA-1088.